We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+25.49%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$918M
AUM Growth
+$106M
(+13%)
Cap. Flow
-$46.8M
Cap. Flow
% of AUM
-5.1%
Top 10 Holdings %
Top 10 Hldgs %
48.26%
Holding
69
New
15
Increased
16
Reduced
21
Closed
14
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$38.1M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$29.8M |
| 3 |
AstraZeneca
AZN
|
+$18.5M |
| 4 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
+$18.5M |
| 5 |
Biogen
BIIB
|
+$13.9M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$39.5M |
| 2 |
HCA Healthcare
HCA
|
+$23.2M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$20.9M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$18.8M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$15.3M |
Sector Composition
| 1 | Healthcare | 79.69% |
| 2 | Technology | 2.51% |
| 3 | Communication Services | 1.69% |
| 4 | Financials | 0.72% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
1
DELISTED
Amicus Therapeutics
FOLD
| $57.2M | 6.23% |
6,875,274
+1,168,368
| +20% | +$8.02M |
|
|
ARRY
2
DELISTED
Array Biopharma Inc
ARRY
| $56.1M | 6.11% |
11,858,294
+3,516,249
| +42% | +$13.9M |
|
3
Bausch Health
BHC
$1.83B
| $48.4M | 5.27% |
338,477
+5,910
| +2% | +$795K |
|
|
CMRX
4
DELISTED
Chimerix, Inc.
CMRX
| $46.6M | 5.07% |
1,157,184
+36,152
| +3% | +$1.22M |
|
|
RAD
5
DELISTED
Rite Aid Corporation
RAD
| $45.4M | 4.94% |
301,937
+38,901
| +15% | +$4.32M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $40.4M | 4.4% |
721,632
-62,827
| -8% | -$3.3M |
|
|
RCPT
7
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $38.3M | 4.17% |
312,736
-127,142
| -29% | -$12.9M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $38.3M | 4.17% |
342,349
-27,051
| -7% | -$2.85M |
|
|
ADVM
9
DELISTED
Adverum Biotechnologies
ADVM
| $37.8M | 4.11% |
69,907
-39
| -0.1% | -$15K |
|
|
10
Gilead Sciences
GILD
$164B
| $34.7M | 3.78% |
+368,615
| New | +$38.1M |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $31.6M | 3.44% |
983,966
+855,736
| +667% | +$29.8M |
|
|
TRIV
12
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $22.1M | 2.4% |
1,755,568
+4,050
| +0.2% | +$55.2K |
|
|
ZSPH
13
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $21.8M | 2.37% |
524,702
+50,570
| +11% | +$2M |
|
|
TVTY
14
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $21.2M | 2.31% |
1,068,489
+41,986
| +4% | +$686K |
|
15
Standard BioTools
LAB
$329M
| $20.6M | 2.24% |
610,442
+50,820
| +9% | +$1.44M |
|
|
16
AstraZeneca
AZN
$261B
| $18.2M | 1.98% |
+258,305
| New | +$18.5M |
|
17
McKesson
MCK
$93.2B
| $18.2M | 1.98% |
87,523
-74,242
| -46% | -$15.1M |
|
18
Puma Biotechnology
PBYI
$428M
| $17.8M | 1.93% |
93,865
+42,840
| +84% | +$9.5M |
|
|
NSTG
19
DELISTED
NanoString Technologies, Inc.
NSTG
| $17.6M | 1.92% |
1,266,538
-187,117
| -13% | -$2.28M |
|
|
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $17.5M | 1.9% |
990,810
-12,686
| -1% | -$198K |
|
|
BLCM
21
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $17.3M | 1.88% |
+86,081
| New | +$18.5M |
|
|
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
| $16.9M | 1.84% |
358,679
-139,762
| -28% | -$5.83M |
|
|
HNT
23
DELISTED
HEALTH NET INC
HNT
| $16.5M | 1.8% |
309,045
-25,890
| -8% | -$1.27M |
|
24
ProQR Therapeutics
PRQR
$250M
| $15.7M | 1.71% |
751,171
-14,061
| -2% | -$213K |
|
25
Insmed
INSM
$23.8B
| $15.7M | 1.71% |
1,012,371
-78,253
| -7% | -$1.11M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO